The prevalence of iCTLA-4hi within CD4+ TIL was associated with ERneg and PRneg BC, the IHC clinical subtypes, a TLS presence and PD-L1+ TIL (Table S9B in Supplementary Material), although these findings were not statically significant after P-value corrections for multiple testing. Here, CD274 is linked to breast cancer.